ProCE Banner Activity

Express Points
Transforming Modern Care in NSCLC: Navigating Advances in New and Emerging Biomarkers to Guide Precision Treatment Decisions

Slideset Download
Download these expert-selected summary slides to learn strategies in assessing and using biomarkers to guide treatment decisions for your patients with NSCLC.

Released: May 07, 2021

Expiration: May 06, 2022

No longer available for credit.

Share

Faculty

Matthew Gubens

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Lauren L. Ritterhouse

Lauren L. Ritterhouse, MD

Assistant Professor
Department of Pathology
Harvard Medical School
Associate Director
Center for Integrated Diagnostics
Department of Pathology
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Janssen administered by Scientific Affairs

Faculty Disclosure

Primary Author

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Lauren L. Ritterhouse, MD

Assistant Professor
Department of Pathology
Harvard Medical School
Associate Director
Center for Integrated Diagnostics
Department of Pathology
Massachusetts General Hospital
Boston, Massachusetts